Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

NCT04147858 is registered in ClinicalTrials.gov with Aptinyx as lead sponsor.

NCT NCT04147858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04147858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
Lead sponsor
Aptinyx
Phase
Phase 2
Overall status
Completed
Start date
November 12, 2019
Completion date
June 16, 2022
Enrollment
310 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia